 |
 |

Why Do Some Individuals Have More Infections Than Others?
Jerry A. Winkelstein, MD;
Barton Childs, MD
JAMA. 2001;285:1348-1349.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The research by Koch and colleagues1 reported in this issue of THE JOURNAL addresses an important clinical question: Why do some people get more infections than others? There are numerous examples of genetically determined variations in the human immune system that influence the ability to respond effectively to the challenges that microorganisms present. The most obvious are the genetically determined primary immunodeficiency diseases. These complete deficiencies of one or another component of the immune system, such as X-linked agammaglobulinemia, markedly increase susceptibility to a wide variety of infections.2 However, these uncommon and dramatic deficiencies of the immune system are only 1 example of genetically determined variations in the immune system that can lead to increased susceptibility to infection.
Many other genetically determined variations, more common and less dramatic, also influence the ability to resist infection.3 For example, many individual components of the immune . . . [Full Text of this Article]
Author Affiliation: Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Acute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early Childhood
Anders Koch, Mads Melbye, Per Sørensen, Preben Homøe, Hans Ole Madsen, Kåre Mølbak, Christoffer Holst Hansen, Lasse Høgh Andersen, Gitte Weinkauff Hahn, and Peter Garred
JAMA. 2001;285(10):1316-1321.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Role of X Inactivation and Cellular Mosaicism in Women's Health and Sex-Specific Diseases
Migeon
JAMA 2006;295:1428-1433.
ABSTRACT
| FULL TEXT
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT
| FULL TEXT
|